Skip to content
Valuesider
Guess what? Valuesider just got better: smarter and more intuitive.
Teva Pharma Industries Ltd ADR

TEVA

Teva Pharma Industries Ltd ADR

Teva Pharma Industries Ltd ADR 13F Holders

TEVA Stock Ownership Activity

# of activities:
2
AVG reported price*:
$30.12
Current price*:
+21.10%($36.48)
2 value investing gurus have made changes to the Teva Pharma Industries Ltd ADR (TEVA) position according to the gurus' 2026 Q1 SEC quarterly report(s). The number of TEVA shares has been decreased by 2 super investor(s).

Which gurus or hedge funds bought TEVA in 2026 Q1?

According to the 2026 Q1 SEC filing(s) Teva Pharma Industries Ltd ADR (TEVA) has not been purchased by any super investor.
To see more about who is investing in Teva Pharma Industries Ltd ADR (TEVA), please go to the TEVA ownership page.
2 results
History Name Company % or
activity 		Shares
change 		Shares
held after* 		% change
to portfolio 		% of
portfolio 		Held since* Held for*
David Einhorn
Greenlight Capital
-4.84%
-148,005
2,910,729
-0.16%
2.75%
2023 Q4
≈ 2.50 years
Harry Burn
Sound Shore Management
-9.84%
-424,223
3,885,683
-0.41%
3.92%
2023 Q3
≈ 2.75 years
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.